Dopaminergic Therapy Improves Cognitive Motivation in Parkinson’s Patients, Study Reports
Dopaminergic treatment normalizes cognitive motivation in patients with Parkinson’s disease, making them more likely to choose a higher reward…
Articles by José Lopes, PhD
In US, Parkinson’s Diagnosis Linked to Higher Healthcare Use, Spending, Study Shows
A diagnosis of Parkinson’s disease is associated with greater Medicare costs and out-of-pocket spending, according to a population-based study…
Physical Activity, Coffee, Moderate Alcohol Consumption Protect Against Disease Progression, Study Reports
Physical activity and participation in competitive sports, as well as coffee, caffeinated tea or moderate alcohol consumption before diagnosis, protect…
Deep Brain Stimulation Technique Lessens Parkinson’s Dyskinesia, Study Finds
Using a parameter called interleaving stimulation (ILS) in deep brain stimulation (DBS) eased dyskinesia — involuntary, jerky movements — in…
Forced Exercise Improves Mobility, Mood in PD Patient, Study Finds
A collaboration between Theracycle and Virginian Outpatient Therapy will replicate a forced exercise regimen on a motorized bicycle…
Add-on Azilect Safe and Effective in Levodopa-treated PD Patients, Phase 3 Trial in Japan Shows
Using Azilect (rasagiline) as an add-on therapy to levodopa was safe and improved motor function over one year…
Smartphone App Can Identify Early Symptoms of Motor Disorders, Study Reports
A smartphone application using a touch-based model is able to accurately identify early signs of motor disorders, according to…
Sirion and Denali Collaborating to Develop Gene Therapies for Neurodegenerative Diseases
Sirion Biotech and Denali Therapeutics have agreed to partner on the development of gene therapies for Parkinson’s disease and…
Inbrija Approved in US to Treat Off Periods in Parkinson’s Patients on Carbidopa/Levodopa
The U.S. Food and Drug Administration has approved Inbrija (levodopa inhalation powder)‎ for the treatment of Parkinson’s off…
Phase 2 Trial of Gene Therapy VY-AADC to Include More Parkinson’s Patients
The ongoing Phase 2 study of the gene therapy VY-AADC will enroll more Parkinson’s disease patients than originally planned,…